SCHEMBL15030783

SCHEMBL15030783

O=c1c2ccc3ccccc3c2oc2c1ccc1ccccc12

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCG2 Q9UNQ0 5/20 0.60
▸ KMT2A Q03164 3/20 0.58
▸ ABCC1 P33527 3/20 0.55
▸ KDM4E B2RXH2 6/20 0.54
▸ ALDH1A1 P00352 5/20 0.54
▸ HPGD P15428 5/20 0.54
▸ MAPT P10636 4/20 0.54
▸ HTT P42858 4/20 0.54
▸ CYP1A1 P04798 3/20 0.54
▸ CYP1B1 Q16678 3/20 0.54
▸ HSD17B10 Q99714 2/20 0.54
▸ POLB P06746 2/20 0.54
▸ CYP1A2 P05177 2/20 0.54
▸ PRKDC P78527 2/20 0.54
▸ ALOX15 P16050 1/20 0.54
▸ PDE5A O76074 1/20 0.54
▸ TP53 P04637 1/20 0.54
▸ ABCB1 P08183 1/20 0.54
▸ CYP3A4 P08684 1/20 0.54
▸ CYP2D6 P10635 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12764548 0.88 MAOA (0.61) ABCG2KMT2AABCC1KDM4EALDH1A1
SCHEMBL22337283 0.88 ABCG2 (0.50) ABCG2KMT2AABCC1KDM4EALDH1A1
SCHEMBL5470220 0.86 HPRT1 (0.57) ABCG2KMT2AABCC1KDM4EALDH1A1
SCHEMBL30154375 0.86 HPRT1 (0.57) ABCG2KMT2AABCC1KDM4EALDH1A1
SCHEMBL28398726 0.83 MAOA (0.66) ABCG2ABCC1KDM4EALDH1A1CYP1A1
SCHEMBL28402137 0.80 KMT2A (0.55) ABCG2KMT2AABCC1KDM4EALDH1A1
SCHEMBL22337130 0.80 KMT2A (0.48) ABCG2KMT2AABCC1KDM4EALDH1A1
SCHEMBL13085233 0.79 HPRT1 (0.70) ABCG2KMT2AABCC1KDM4EALDH1A1
SCHEMBL3081576 0.79 ARSA (0.56) ABCG2KMT2AABCC1KDM4EALDH1A1
SCHEMBL22326344 0.79 KMT2A (0.47) ABCG2KMT2AABCC1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10305040-B2 Spiro dihydroacridine derivatives and the use thereof as materials for organic electroluminescence devices MERCK PATENT GMBH (DE) 2019-05-28 — — US disclosed
EP-2780325-B1 SPIRO-DIHYDROACRIDINE DERIVATIVES AND THEIR USE AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2016-02-03 — — EP disclosed
US-20140316134-A1 SPIRO DIHYDROACRIDINE DERIVATIVES AND THE USE THEREOF AS MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES MERCK PATENT GMBH (DE) 2014-10-23 — — US disclosed
US-20140316134-A1 SPIRO DIHYDROACRIDINE DERIVATIVES AND THE USE THEREOF AS MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES MERCK PATENT GMBH (DE) 2014-10-23 — — US disclosed
WO-2013083216-A1 SPIRO DIHYDROACRIDINE DERIVATIVES AND THE USE THEREOF AS MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES MERCK PATENT GMBH (DE) 2013-06-13 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10305040-B2 Spiro dihydroacridine derivatives and the use thereof as materials for organic electroluminescence devices SORD, ALDH1A1, SDHA ABCG2 899/4885KMT2A 3341/4885ABCC1 463/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback